These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 26369922)

  • 41. A multi-component universal intervention to improve diet and physical activity among adults with intellectual disabilities in community residences: a cluster randomised controlled trial.
    Bergström H; Hagströmer M; Hagberg J; Elinder LS
    Res Dev Disabil; 2013 Nov; 34(11):3847-57. PubMed ID: 24021393
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Motivational interviewing: an intervention tool for child welfare case workers working with substance-abusing parents.
    Hohman MM
    Child Welfare; 1998; 77(3):275-89. PubMed ID: 9599421
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Young athletes' awareness and monitoring of anti-doping in daily life: Does motivation matter?
    Chan DK; Donovan RJ; Lentillon-Kaestner V; Hardcastle SJ; Dimmock JA; Keatley DA; Hagger MS
    Scand J Med Sci Sports; 2015 Dec; 25(6):e655-63. PubMed ID: 25441263
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Substance use among individuals with mild intellectual disability or borderline intellectual functioning in residential care: Examining the relationship between drinking motives and substance use.
    Schijven EP; Didden R; Otten R; Poelen EAP
    J Appl Res Intellect Disabil; 2019 Jul; 32(4):871-878. PubMed ID: 30844128
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Longitudinal relations between substance use abstinence motivations and substance use behaviors in adolescence: A self-determination theory approach.
    Moore JP; Hardy SA
    J Pers; 2020 Aug; 88(4):735-747. PubMed ID: 31651040
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Demographic and clinical characteristics of people with intellectual disabilities with and without substance abuse disorders in a Medicaid population.
    Slayter EM
    Intellect Dev Disabil; 2010 Dec; 48(6):417-31. PubMed ID: 21166548
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Motivational tools to improve probationer treatment outcomes.
    Taxman FS; Walters ST; Sloas LB; Lerch J; Rodriguez M
    Contemp Clin Trials; 2015 Jul; 43():120-8. PubMed ID: 26009023
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Substance abuse among individuals with intellectual disabilities.
    Carroll Chapman SL; Wu LT
    Res Dev Disabil; 2012; 33(4):1147-56. PubMed ID: 22502840
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Engaging Youth (Adolescents and Young Adults) to Change Frequent Marijuana Use: Motivational Enhancement Therapy (MET) in Primary Care.
    Kells M; Burke PJ; Parker S; Jonestrask C; Shrier LA
    J Pediatr Nurs; 2019; 49():24-30. PubMed ID: 31473464
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Homosexuality among people with a mild intellectual disability: an explorative study on the lived experiences of homosexual people in the Netherlands with a mild intellectual disability.
    Stoffelen J; Kok G; Hospers H; Curfs LM
    J Intellect Disabil Res; 2013 Mar; 57(3):257-67. PubMed ID: 23379862
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Abstinence based incentives plus parent training for adolescent alcohol and other substance misuse.
    Stanger C; Scherer EA; Babbin SF; Ryan SR; Budney AJ
    Psychol Addict Behav; 2017 Jun; 31(4):385-392. PubMed ID: 28414474
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Motivational interviewing in substance abuse: applications for occupational medicine.
    Miller JH; Moyers T
    Occup Med; 2002; 17(1):51-65, iv. PubMed ID: 11726336
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modeling motivation three ways: effects of MI metrics on treatment outcomes among adolescents.
    Hall BC; Stewart DG; Arger C; Athenour DR; Effinger J
    Psychol Addict Behav; 2014 Mar; 28(1):307-12. PubMed ID: 24467198
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autonomy support in people with mild-to-borderline intellectual disability: Testing the Health Care Climate Questionnaire-Intellectual Disability.
    Frielink N; Schuengel C; Embregts PJCM
    J Appl Res Intellect Disabil; 2018 Jan; 31(1):159-163. PubMed ID: 28544437
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term effect of motivational interviewing on clinical and psychological outcomes and health-related quality of life in cardiac rehabilitation patients with poor motivation in Hong Kong: a randomized controlled trial.
    Chair SY; Chan SW; Thompson DR; Leung KP; Ng SK; Choi KC
    Clin Rehabil; 2013 Dec; 27(12):1107-17. PubMed ID: 23828185
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Personality dimensions and substance use in individuals with mild to borderline intellectual disabilities.
    Poelen EA; Schijven EP; Otten R; Didden R
    Res Dev Disabil; 2017 Apr; 63():142-150. PubMed ID: 27765413
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mindfulness-based cognitive therapy for adults with intellectual disabilities: an evaluation of the effectiveness of mindfulness in reducing symptoms of depression and anxiety.
    Idusohan-Moizer H; Sawicka A; Dendle J; Albany M
    J Intellect Disabil Res; 2015 Feb; 59(2):93-104. PubMed ID: 24020487
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Job satisfaction of people with intellectual disabilities: the role of basic psychological need fulfillment and workplace participation.
    Akkerman A; Kef S; Meininger HP
    Disabil Rehabil; 2018 May; 40(10):1192-1199. PubMed ID: 28288522
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessing the Efficacy of MOTI-4 for Reducing the Use of Cannabis Among Youth in the Netherlands: A Randomized Controlled Trial.
    Dupont HB; Candel MJ; Kaplan CD; van de Mheen D; de Vries NK
    J Subst Abuse Treat; 2016 Jun; 65():6-12. PubMed ID: 26780988
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders.
    Barrowclough C; Haddock G; Tarrier N; Lewis SW; Moring J; O'Brien R; Schofield N; McGovern J
    Am J Psychiatry; 2001 Oct; 158(10):1706-13. PubMed ID: 11579006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.